OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expression and Roles of Antimicrobial Peptides in Innate Defense of Airway Mucosa: Potential Implication in Cystic Fibrosis
Régina Geitani, Carole Ayoub Moubareck, Zhengzhong Xu, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Mucosal immune responses to infection and vaccination in the respiratory tract
Robert C. Mettelman, E. Kaitlynn Allen, Paul G. Thomas
Immunity (2022) Vol. 55, Iss. 5, pp. 749-780
Open Access | Times Cited: 153

Multitalented Synthetic Antimicrobial Peptides and Their Antibacterial, Antifungal and Antiviral Mechanisms
Tania Vanzolini, Michela Bruschi, Andrea C. Rinaldi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 545-545
Open Access | Times Cited: 70

A review on the screening methods for the discovery of natural antimicrobial peptides
Bin Yang, Hongyan Yang, Jianlong Liang, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 15, Iss. 1, pp. 101046-101046
Open Access | Times Cited: 47

Mucus Structure, Viscoelastic Properties, and Composition in Chronic Respiratory Diseases
Michela Abrami, Alice Biasin, Fabiana Tescione, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1933-1933
Open Access | Times Cited: 18

Attacins: A Promising Class of Insect Antimicrobial Peptides
Francesco Buonocore, Anna Maria Fausto, Giulia Della Pelle, et al.
Antibiotics (2021) Vol. 10, Iss. 2, pp. 212-212
Open Access | Times Cited: 64

The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
Caitlyn Harvey, Sinéad Weldon, J.S. Elborn, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3513-3513
Open Access | Times Cited: 40

Current status of development and biomedical applications of peptide-based antimicrobial hydrogels
Huihui Qu, Quanfu Yao, Ting Chen, et al.
Advances in Colloid and Interface Science (2024) Vol. 325, pp. 103099-103099
Closed Access | Times Cited: 10

Antimicrobial peptides: Defending the mucosal epithelial barrier
Karen F. Johnstone, Mark C. Herzberg
Frontiers in Oral Health (2022) Vol. 3
Open Access | Times Cited: 28

Immunomodulatory Properties of Vitamin D in the Intestinal and Respiratory Systems
Fatheia N. Hamza, Sarah Daher, Hana Fakhoury, et al.
Nutrients (2023) Vol. 15, Iss. 7, pp. 1696-1696
Open Access | Times Cited: 20

Antimicrobial Peptides (AMPs) and the Microbiome in Preterm Infants: Consequences and Opportunities for Future Therapeutics
Janina Marißen, Lilith Reichert, Christoph Härtel, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6684-6684
Open Access | Times Cited: 6

Antimicrobial peptides: features, applications and the potential use against covid-19
Dalia M. Mabrouk
Molecular Biology Reports (2022) Vol. 49, Iss. 10, pp. 10039-10050
Open Access | Times Cited: 25

Cystic Fibrosis and the Cells of the Airway Epithelium: What Are Ionocytes and What Do They Do?
Viral S. Shah, Raghu R. Chivukula, Brian Lin, et al.
Annual Review of Pathology Mechanisms of Disease (2021) Vol. 17, Iss. 1, pp. 23-46
Open Access | Times Cited: 32

Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome through Modulation of Microbiome in the Gut-Lung Axis
Muthanna Sultan, Kiesha Wilson, Osama A. Abdulla, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3305-3305
Open Access | Times Cited: 30

Staphylococcus epidermidis Controls Opportunistic Pathogens in the Nose, Could It Help to Regulate SARS-CoV-2 (COVID-19) Infection?
Silvestre Ortega‐Peña, Sandra Rodríguez‐Martínez, Mario E. Cancino‐Díaz, et al.
Life (2022) Vol. 12, Iss. 3, pp. 341-341
Open Access | Times Cited: 14

Zearalenone induces immuno-compromised status via TOR/NF/κB pathway and aggravates the spread of Aeromonas hydrophila to grass carp gut (Ctenopharyngodon idella)
Hongyun Zhang, Yali Wang, Xiao‐Qiu Zhou, et al.
Ecotoxicology and Environmental Safety (2021) Vol. 225, pp. 112786-112786
Open Access | Times Cited: 19

Antimicrobial peptides for tackling cystic fibrosis related bacterial infections: A review
Francesca Bugli, Cécilia Martini, Maura Di Vito, et al.
Microbiological Research (2022) Vol. 263, pp. 127152-127152
Open Access | Times Cited: 13

Exploring the role of RNASET2 in the immune response of black soldier fly larvae
Sara Caramella, Nicoló Baranzini, Daniele Bruno, et al.
Archives of Insect Biochemistry and Physiology (2024) Vol. 116, Iss. 4
Open Access | Times Cited: 2

Effect of Camel Peptide on the Biofilm of Staphylococcus epidermidis and Staphylococcus haemolyticus Formed on Orthopedic Implants
J Nowicka, Adriana Janczura, Magdalena Pajączkowska, et al.
Antibiotics (2023) Vol. 12, Iss. 12, pp. 1671-1671
Open Access | Times Cited: 6

Lung-Centric Inflammation of COVID-19: Potential Modulation by Vitamin D
Hana Fakhoury, Peter R. Kvietys, Ismail Shakir, et al.
Nutrients (2021) Vol. 13, Iss. 7, pp. 2216-2216
Open Access | Times Cited: 15

Bps polysaccharide of Bordetella pertussis resists antimicrobial peptides by functioning as a dual surface shield and decoy and converts Escherichia coli into a respiratory pathogen
Audra R. Fullen, Jessica L. Gutierrez-Ferman, Kacy S. Yount, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 8, pp. e1010764-e1010764
Open Access | Times Cited: 10

Influenza A–induced cystic fibrosis transmembrane conductance regulator dysfunction increases susceptibility to Streptococcus pneumoniae
Erin Y. Earnhardt, Jennifer L. Tipper, Adonis D’Mello, et al.
JCI Insight (2023) Vol. 8, Iss. 14
Open Access | Times Cited: 5

Emerging drug delivery systems with traditional routes – A roadmap to chronic inflammatory diseases
Kiyoon Min, Abhishek Sahu, Sae Hyun Jeon, et al.
Advanced Drug Delivery Reviews (2023) Vol. 203, pp. 115119-115119
Closed Access | Times Cited: 5

Current and novel therapeutic strategies for the management of cystic fibrosis
Douweh Leyla Gbian, Abdelwahab Omri
Expert Opinion on Drug Delivery (2021) Vol. 18, Iss. 5, pp. 535-552
Closed Access | Times Cited: 11

Page 1 - Next Page

Scroll to top